These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10696560)

  • 21. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema.
    Rongioletti F; Rebora A
    J Am Acad Dermatol; 2001 Feb; 44(2):273-81. PubMed ID: 11174386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute rhabdomyolysis during the treatment of scleromyxedema with interferon alfa.
    Ozdag F; Akar A; Eroglu E; Erbil H
    J Dermatolog Treat; 2001 Sep; 12(3):167-9. PubMed ID: 12243709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins.
    Wojas-Pelc A; Błaszczyk M; Glińska M; Jabłońska S
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):462-5. PubMed ID: 15987294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scleromyxedema.
    Harris AO; Altman AR; Tschen JA; Wolf JE
    Int J Dermatol; 1989 Dec; 28(10):661-7. PubMed ID: 2592129
    [No Abstract]   [Full Text] [Related]  

  • 25. Skin induration with multiple flesh-colored papules. Scleromyxedema.
    Mancini AJ; Kim YH
    Arch Dermatol; 1998 Jan; 134(1):97, 100. PubMed ID: 9449916
    [No Abstract]   [Full Text] [Related]  

  • 26. [Scleromyxedema as a systemic disease of glycosaminoglycan accumulation].
    Radenska-Lopovok SG; Volkova P; Gorodetsky VR; Egorova ON; Ananyeva LP
    Arkh Patol; 2018; 80(3):53-58. PubMed ID: 29927441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Internal disease findings in Arndt-Gottron scleromyxedema].
    Lang E; Goos M
    Dtsch Med Wochenschr; 1986 May; 111(21):820-3. PubMed ID: 3084193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two cases of scleromyxedema.
    Jepsen LV
    Acta Derm Venereol; 1980; 60(1):77-79. PubMed ID: 6153843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of intractable scleromyxedema with cyclosporin A.
    Saigoh S; Tashiro A; Fujita S; Matsui M; Shibata S; Takeshita H; Duan H; Moroi Y; Urabe K; Koga T; Furue M
    Dermatology; 2003; 207(4):410-1. PubMed ID: 14657639
    [No Abstract]   [Full Text] [Related]  

  • 30. Scleromyxedema with dermato-neuro syndrome.
    Gonzalez J; Palangio M; Schwartz J; Klainer AS; Bisaccia E
    J Am Acad Dermatol; 2000 May; 42(5 Pt 2):927-8. PubMed ID: 10767707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous immunoglobulin therapy for scleromyxedema: a case report and review of literature.
    Sroa N; Campbell S; Bechtel M
    J Drugs Dermatol; 2010 Mar; 9(3):263-5. PubMed ID: 20232589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resident Rounds part III: scleromyxedema: a rare disorder associated with a monoclonal gammopathy.
    Mandell JA; Glick JB; Kaur RR
    J Drugs Dermatol; 2014 May; 13(5):619-20. PubMed ID: 24809891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thalidomide as a potential treatment for scleromyxedema.
    Caradonna S; Jacobe H
    Arch Dermatol; 2004 Mar; 140(3):277-80. PubMed ID: 15023770
    [No Abstract]   [Full Text] [Related]  

  • 34. Allogeneic stem cell transplantation for the treatment of refractory scleromyxedema.
    Shayegi N; Alakel N; Middeke JM; Schetelig J; Mantovani-Löffler L; Bornhäuser M
    Transl Res; 2015 Feb; 165(2):321-4. PubMed ID: 24999269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scleromyxedema: a scleroderma-like disorder with systemic manifestations.
    Gabriel SE; Perry HO; Oleson GB; Bowles CA
    Medicine (Baltimore); 1988 Jan; 67(1):58-65. PubMed ID: 3336281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Scleromyxedema associated with myopathy].
    Catalá J; López-Aldeguer J; Vílchez JJ; Chirivella M; Catalá MT
    Rev Clin Esp; 1993 Jul; 193(3):119-21. PubMed ID: 8356289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scleromyxedema: a complete response to prednisone.
    Rayson D; Lust JA; Duncan A; Su WP
    Mayo Clin Proc; 1999 May; 74(5):481-4. PubMed ID: 10319080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Scleromyxedema therapy with isotretinoin].
    Lominska-Lasota K; Rosen-Uzelac G; Reichl W; Bauer R
    Z Hautkr; 1988 Feb; 63(2):137-8, 141. PubMed ID: 3163867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus.
    Khorshid O; Hosing C; Bibawi S; Ueno N; Reveille J; Mayes MD; Champlin RE
    J Rheumatol; 2004 Dec; 31(12):2513-6. PubMed ID: 15570660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Arndt-Gottron scleromyxedema].
    Piper W; Hardmeier T
    Verh Dtsch Ges Inn Med; 1967; 73():394-9. PubMed ID: 5591783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.